Genomic Studies Reveal Shared and Distinct Biology of Binge Eating, Anorexia

Eating disorders have long been described through visible symptoms: restricting food, losing weight, or consuming unusually large amounts in a short period. A new genomic analysis suggests that these behaviors are connected to a far more complicated biological landscape than symptom-based labels alone can reveal. In a study published in Nature Mental Health, researchers analyzed the genetic architecture of binge-eating behavior alongside anorexia nervosa, identifying biological signals that appear to be shared across eating-disorder phenotypes as well as others that distinguish them. The findings could reshape how scientists understand why apparently opposite behaviors—persistent restriction and recurrent overeating—can emerge from overlapping systems involving the brain, metabolism and mental health.

The study, led by Janneke D. Termorshuizen, Hannah L. Davies, Su Hyun Lee and colleagues, uses genomic meta-analysis, a method that combines results from multiple genetic studies to increase statistical power. Researchers typically begin with genome-wide association studies, or GWAS, which scan millions of small DNA differences across the genomes of large groups of people. Each individual variant usually has an extremely small effect on behavior or disease risk. By analyzing them together across many participants and datasets, scientists can detect cumulative patterns that would be invisible in a smaller study. The approach does not identify a single “binge-eating gene” or “anorexia gene”; instead, it maps a distributed genetic propensity involving thousands of variants.

Binge-eating behavior refers to episodes in which a person consumes an unusually large amount of food while experiencing a sense of loss of control. It can occur as part of binge-eating disorder, bulimia nervosa or other clinical conditions, but it is also measured dimensionally in the general population. That distinction matters because symptoms do not always fit neatly into diagnostic categories. Anorexia nervosa, by contrast, is characterized by persistent restriction of energy intake, intense fear of weight gain or behavior that prevents weight gain, and disturbances in the way body weight or shape is experienced. Although these conditions appear behaviorally opposite, both involve powerful changes in appetite, reward processing, emotional regulation and decision-making.

By placing binge-eating behavior and anorexia nervosa in the same genomic framework, the researchers were able to ask a deeper question: which biological mechanisms are common to eating-disorder risk, and which may push individuals toward one behavioral pattern rather than another? The results indicate that the two phenotypes share some genetic liability, supporting the idea that eating disorders are not completely separate illnesses. Common influences may involve neural circuits that regulate reward, impulse control, stress responses and the relationship between internal bodily signals and conscious behavior. At the same time, the genetic profiles also showed meaningful differences, suggesting that partially distinct biological pathways contribute to compulsive overeating and restrictive illness.

One important implication is that eating disorders may be better understood as interconnected traits rather than isolated diagnostic boxes. Genetic correlation analyses can estimate whether the same variants that increase the likelihood of one trait also tend to influence another. A positive correlation does not mean that one condition causes the other, nor does it predict an individual’s fate. It indicates that, at the population level, some biological factors are statistically shared. The study’s comparison of binge-eating behavior with anorexia nervosa highlights how this shared architecture can coexist with opposing associations involving appetite, energy balance, mood, cognition and body-weight regulation.

The findings also reinforce a growing shift in anorexia nervosa research. For decades, anorexia was often framed primarily as a disorder of fear, control or body image. Genetic studies have increasingly shown that the condition also has metabolic and physiological dimensions. Signals associated with energy regulation, weight maintenance and the body’s response to nutritional deprivation may interact with psychiatric vulnerabilities. Binge-eating behavior, meanwhile, may be influenced by a different balance between reward sensitivity, satiety signaling, emotional distress and behavioral control. These distinctions could help explain why treatments that work for one eating-disorder phenotype may be ineffective—or even inappropriate—for another.

The researchers’ use of genomic data also offers a way to examine links between eating-disorder traits and other conditions. Polygenic scores, which summarize the combined effects of many genetic variants, can be used in research to test whether a person’s inherited susceptibility to one trait overlaps with susceptibility to another. Such scores are not diagnostic tests and cannot determine whether someone will develop an eating disorder. However, they can help investigators study connections with psychiatric characteristics, metabolic traits and health outcomes across populations. This may eventually clarify why some people with binge-eating symptoms also experience depression, impulsivity or metabolic disease, while others show a different clinical pattern.

The work carries a warning against interpreting genetic risk as destiny. Genes operate within environments shaped by food availability, stress, trauma, social pressures, cultural ideals, sleep, medication, physical health and relationships. The same biological tendency may produce different outcomes under different circumstances. A person may carry genetic variants associated with appetite regulation or emotional reactivity without ever developing an eating disorder. Conversely, someone with no obvious family history can become seriously ill. Genomic findings are most useful when they are combined with clinical observation and an understanding of the social and developmental conditions in which symptoms arise.

For patients, the study does not immediately produce a new treatment or a clinical genetic test. Its significance is more foundational: it provides evidence that the biology of eating disorders is both shared and divided in ways that current labels may not fully capture. Future research could use these findings to identify molecular pathways involved in appetite, reward, stress and energy balance, then test whether they can be targeted safely. It may also support more personalized care, in which treatment decisions reflect the patient’s dominant symptoms, medical risks and psychological needs rather than assuming that every eating disorder follows the same mechanism.

The broader message is that binge eating and anorexia nervosa should not be treated as simple opposites or as conditions explained by willpower. They are complex brain-body disorders with overlapping genetic foundations and distinct biological signatures. By analyzing both phenotypes together, Termorshuizen, Davies, Lee and their colleagues provide a map of that complexity, showing why some vulnerabilities may cross diagnostic boundaries while others steer illness toward restriction or loss-of-control eating. The study brings eating-disorder science closer to a model in which genes, metabolism, neural circuits and lived experience interact—and in which better classification could ultimately lead to earlier recognition and more precise treatment.